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Abstract. Three-dimensional (3D) gel dosimetry has a unique role to play in safeguarding 
conformal radiotherapy treatments as the technique can cover the full treatment chain and 
provides the radiation oncologist with the integrated dose distribution in 3D. It can also be 
applied to benchmark new treatment strategies such as image guided and tracking radiotherapy 
techniques. A major obstacle that has hindered the wider dissemination of gel dosimetry in 
radiotherapy centres is a lack of confidence in the reliability of the measured dose distribution. 
Uncertainties in 3D dosimeters are attributed to both dosimeter properties and scanning 
performance. In polymer gel dosimetry with MRI readout, discrepancies in dose response of 
large polymer gel dosimeters versus small calibration phantoms have been reported which can 
lead to significant inaccuracies in the dose maps. The sources of error in polymer gel dosimetry 
with MRI readout are well understood and it has been demonstrated that with a carefully 
designed scanning protocol, the overall uncertainty in absolute dose that can currently be 
obtained falls within 5% on an individual voxel basis, for a minimum voxel size of 5 mm3. 
However, several research groups have chosen to use polymer gel dosimetry in a relative 
manner by normalizing the dose distribution towards an internal reference dose within the gel 
dosimeter phantom. 3D dosimetry with optical scanning has also been mostly applied in a 
relative way, although in principle absolute calibration is possible. As the optical absorption in 
3D dosimeters is less dependent on temperature it can be expected that the achievable accuracy 
is higher with optical CT. The precision in optical scanning of 3D dosimeters depends to a 
large extend on the performance of the detector. 3D dosimetry with X-ray CT readout is a low 
contrast imaging modality for polymer gel dosimetry. Sources of error in x-ray CT polymer gel 
dosimetry (XCT) are currently under investigation and include inherent limitations in 
dosimeter homogeneity, imaging performance, and errors induced through post-acquisition 
processing. This overview highlights a number of aspects relating to uncertainties in polymer 
gel dosimetry. 
1.  Introduction 
1.1.  3D dose verification with integrating dosimeters 
3D radiation dosimetry provides a unique ability to display dose distributions occurring in clinical 
radiotherapy in three dimensions (3D) in humanoid shaped phantoms [1-3]. It has a unique role to play 
in safeguarding conformal radiotherapy treatments, as it is the only dosimeter that covers the whole 
treatment chain and provides the radiation oncologist with the integrated dose distribution in 3D. 
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Moreover, 3D dosimeters can also be used to benchmark motion compensation radiotherapy 
technologies when mounted in a motion phantom. However, some doubts with respect to the overall 
reliability have overshadowed the wider dissemination of 3D radiation dosimetry in radiation centers.  
1.2.  ‘Absolute’ versus ‘relative’ 3D dosimetry 
Although the terminology ‘absolute’ and ‘relative’ is somewhat ill defined in gel literature, we use the 
term ‘absolute’ to describe the approach where an independent external calibration of the 3D 
dosimeter is applied in contrast to the term ‘relative’ 3D dosimetry, where the 3D dose distribution is 
normalized towards some internal reference points (mostly the dose in the isocentre and the dose in a 
low or high dose region).  
When utilizing polymer gels with MRI readout, significant differences in dose-R2 response have 
been found between different 3D dosimeters that were poured in small calibration vials as compared to 
larger phantom recipients [4, 5]. This finding severely compromises the use of an externally derived 
calibration curve to convert the measured R2 maps to dose maps. Several possible reasons have been 
proposed as explanation for the observed discrepancies such as differences in cooling rate [6], changes 
in temperature during irradiation as a result of the exothermal radiation induced polymerization 
reaction [7] and physicochemical changes related to an oxygen-antioxidant imbalance [8]. To 
circumvent the discrepancies in dose-R2 response between small test tubes and larger volumetric 
anthropomorphic gel dosimeter phantoms, many researchers have chosen to apply an internal 
calibration (i.e. the R2 is calibrated to dose by using two points within the phantom as ‘known’ doses), 
which is further referred to as ‘relative’ dosimetry. Regardless the fact that with an internal calibration, 
the ability of gel dosimetry to safeguard absolute dose information of a treatment is lost, it should also 
be emphasized that there is a potentially more severe danger with this strategy because the mentioned 
mechanisms may depend on radiation dose, dose rate, environmental conditions and size and shape of 
the phantom. Most often, a linear calibration curve is assumed with this approach. There is therefore 
no evidence that the same mechanism for the observed discrepancies would not cause any dose 
measurement errors within the volumetric polymer gel dosimeter phantom itself. Indeed, a major 
source of these discrepancies is attributed to temperature differences during scanning within the 
volumetric dosimeter phantom. 
3D dosimetry using optical readout has mostly been performed with relative or internal calibration, 
although there doesn’t seem to be a specific argument why absolute calibration could not be 
performed. The radiation absorptivity defined as absorption per unit of distance per dose should only 
depend on the dosimeter material and calibration samples can be exposed to known radiation doses 
and either scanned or readout using a benchtop optical spectrometer. Studies are underway to 
determine the uncertainty associated with external dose calibration of dye based plastic dosimeters. 
Early investigations using x-ray CT polymer gel dosimetry (PGD)  utilized linear calibration curves 
and “relative” dosimetry [9, 10] Calibrations were performed either in a purely relative sense 
(assuming a known dose at a given point) or via large phantom irradiation with small fields of known 
doses. However, calibration phantoms were not designed to match test (anthropomorphic) phantoms, 
thus introducing potential errors within the calibration procedure.  Since those early experiments, 
refinements to the overall calibration procedure in x-ray CT PGD have been made. As in the case with 
MRI, it has been recognized that small vial irradiations can not be used to calibrate large test phantoms 
due to the differing response between small and large PGD samples. As mentioned above, this 
observation points to the differential response being due to properties of the gel reaction (exothermic 
etc) as opposed to an imaging modality-based explanation. Furthermore, it has been shown that a 
linear dose response can not be assumed when utilizing high dose-sensitivity polymer gel with x-ray 
CT imaging [11, 12]. Recent experiments have shown that when utilizing a non linear calibration 
curve obtained from the irradiation of a portion of the test phantom with a known dose distribution, 
absolute dosimetry can be performed which results in a dose dependent accuracy and precision, as 
described in further detail below. 
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1.3.  Evaluating the uncertainty of 3D dosimetry 
The evaluation methods that have been applied by many 3D dosimetry research groups to give 
evidence of the ‘potential’ of 3D dosimeters are often based on a percentage number of voxels that 
pass gamma criteria between a measured dose distribution and a treatment planning system (TPS) 
calculated dose distribution. This value of pass rates obviously depends on the number of slices and 
the size (field-of-view) of the dose maps taken into consideration. Some have suggested to use a dose 
threshold in which gamma is calculated but even in this case, care must be taken in using gamma pass 
rates that will still depend on the topological ‘complexity’ of the dose distribution. Although it is 
recognized that gamma maps are a valuable tool in benchmarking a radiotherapy treatment plan, the 
use of a percentage value of passing pixels in benchmarking a dosimetry technique against a TPS 
calculated dose distribution can be misleading as proof of the reliability of the dosimetry technique. 
Gamma map analysis should also be performed with much care as the measured dose distributions 
may contain stochastic noise. Gamma values may be significantly underestimated when the evaluated 
dose distribution contains noise [13]. Moreover, it is not beyond discussion to what extend a TPS 
calculated dose distribution should be used as ‘golden standard’ to benchmark a new dosimeter. Of 
course, it is recognized that the intrinsic problem with the benchmarking of a 3D dosimeter is that 
there does not exist another 3D dosimetric ‘golden standard’ to compare against. The most reasonable 
strategy is to compare doses obtained with gel dosimetry with doses obtained by the most reliable 
dosimetry techniques that apply to a certain spatial dimension. For example, dose profiles of a single 
field (photons and electrons) can be compared with dose profiles obtained with an ionization chamber 
or diamond detector [14, 15]. In two dimensions, 3D dosimetry can be compared with film dosimetry 
[3, 14, 16]. Dose distributions obtained with 3D dosimetry have been compared with those calculated 
with treatment planning software [3, 17-23]. Errors that compromise the accuracy may occur at 
different stages of the dosimetry procedure [24]. Given the uncertainties with respect to the 
calibration, we argue that a more stringent approach using other dosimeters and treatment planning 
should be applied to benchmark 3D radiation dosimetry than a gamma evaluation against a single 
treatment plan. 
1.4.   Accuracy and precision  
 Accuracy is defined as the degree of conformity of a 
measured or calculated quantity (a measurand) to its 
actual (true) value. Precision is defined as the ability of 
a measurement to be consistently reproduced. Accuracy 
and precision can be defined statistically in terms of the 
deviation of the mean value from the reference value 
and the standard deviation of the mean value of many 
measurements respectively (figure 1). The 
measurement uncertainty of a single experiment thus 
comprises both systematic and random errors. 
Uncertainties have further been classified in type A and 
type B uncertainties where type A standard uncertainty 
is obtained from a probability density function derived 
from an observed frequency distribution, while type B 
standard uncertainty is obtained from an assumed 
probability density function that is based on the degree 
of belief that an event will occur. 
In the case of 3D radiation dosimetry, uncertainty 
applies to both dose and space. In a gel dosimetry dose verification experiment (and any radiation 
treatment), the spatial and dosimetric dimensions are interwoven. For large volume dosimeters it is 
theoretically impossible to extract both dosimetric and spatial errors from a measured spatial dose 
distribution (i.e. the result of a 3D gel dosimetry experiment). To comprise both spatial and dosimetric 
 
Figure 1. Accuracy and precision shown 
schematically in terms of probabilities of 
occurrence. Precision can be characterised in 
terms of the standard deviation of many 
measurements (experiments). The accuracy is 
characterized by the deviation of the mean of 
many measurements from the reference 
(known) value. 
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performance in one parameter, Low et al have introduced the gamma-index [25]. Other dose 
distribution comparisons are performed on the basis of maximum allowed dose differences [26]. 
The overall uncertainty of 3D radiation dosimetry can be achieved through a reproducibility study 
of the complete dosimetry experiment from gel fabrication to dose distribution analysis. An extensive 
reproducibility study, comprising the repetition of a gel dosimetry experiment has been carried out for 
polymer gel dosimeters with MRI readout [27]. It is imperative to realize that in a clinical verification 
with gel dosimetry, consisting of a single experiment, the uncertainty of the dose measured in each 
voxel comprises both the systematic inaccuracy and random errors, including stochastic image noise.  
A typical clinical 3D dose verification experiment is performed in different steps and errors can 
occur at each stage (figure 2): (1) The polymer gel dosimeter is fabricated in a chemical laboratory and 
is stored until radiation. Any deviations in the chemical composition through inhomogeneous mixing, 
remnant impurities in the gel container or oxygen permeability within the gel containers can give rise 
to discrepancies between calibration and volumetric phantoms [8]. Moreover, a difference in 
temperature course during storage may also affect the dose-R2 response between calibration and test 
phantoms [6]. Most of these deviations are compensated for by using calibration phantoms that are (i) 
fabricated from the same batch of gel, (ii) of the same material composition, and (iii) of similar 
volumes. (2) The gel dosimeter phantom is then scanned with CT and a treatment plan is devised (3) 
on the CT images, resulting in a virtual planning target volume (PTV) and a set of critical organs. At 
this stage, just as with a patient, a reference coordinate system is allocated to the phantom by use of 
marker lines that are drawn on the phantom. In addition, for co-registration of the dose maps with the 
TPS, stereotactic fixtures or fiducial markers [28] can be placed on the phantom that will later be 
visible on the imaging modality of interest (MRI, optical CT, x-ray CT). Positional setup errors are 
likely to result in deviations between the planned and the measured dose distribution. These deviations 
are not intrinsic to the gel dosimeter but are indicative for errors that may occur during the actual 
patient treatment. (4) Upon irradiation, a complex set of radiation-induced chemical reactions take 
place. On a molecular level, these reactions are probabilistic in nature but on the spatial scale of 





Figure 2.  In a clinical dose verification experiment with 3D dosimetry, the dosimeter phantom is taken through 
the entire treatment chain. Possible dosimetric or setup errors can occur at the different stages. 3D dosimetry 
fulfills an important role in benchmarking the complete treatment chain.  
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Any positional set-up errors in treatment with respect to the planned treatment will affect the dose 
distribution. This error may also occur in patient treatment and is therefore not intrinsic to 3D 
dosimetry. In benchmarking 3D radiation dosimetry however, the experimental set-up error should be 
minimized as much as possible by adequate positioning aids in order to isolate the other error sources. 
Other sources of deviation in dose reading that may occur during irradiation of the gel dosimeter are 
related to the dependence of the irradiation response on the temperature of the 3D dosimeter during 
irradiation, on the dose rate and on the energy spectrum of the irradiation beam [29, 31]. It is 
important to realize that differences in dose rate (and energy) will occur in the irradiated 3D volume 
even if the photon fluence rate (in terms of MU/min) of the individual beams is kept constant. Another 
important characteristic of the dosimeter is its temporal and spatial integrity [32, 33]. These errors are 
inherent to the dosimeter material and should be minimized as they compromise the specificity of the 
dosimeter. After irradiation, the gel dosimeter is imaged (MRI, optical CT, x-ray CT) (5). During 
imaging, image noise will add to the measurements. In order to minimize the noise in the measured 
dose distribution the scanning parameters should be optimized [34-36]. The processing (fitting, 
filtering etc) of acquired data (6), may have a significant influence on the amplification of noise 
inherent in the data. For example, in quantitative R2-NMR scanning it is found that a least-square fit 
will amplify the thermal noise in the base images to a larger extent than a chi-square (χ2) based 
minimization. Imaging artifacts may result in systematic errors both dosimetric and spatially. A 
classification of the error sources in Type A and B uncertainties can be found elsewhere [37]. 
2.  Uncertainties in polymer gel dosimetry with MRI readout 
The overall dosimetric precision is compromised by random errors in the different operations (figure 
2) carried out in the dosimetry experiment. The first step in a gel dosimetry experiment is weighting 
the chemicals. Stochastic variations in the weighting will result in variations in the measured dose-
related value (R1, R2, MT) as the dose-response is determined by the chemical composition. It is found 
that other manufacturing conditions may also have an influence on the dose-response such as the 
temperature during fabrication and the oxygen concentration in the gel dosimeter. Stochastic 
variations in the controlled temperature between different experiments will therefore also lead to 
variations in the measured dose-related value. These variations only contribute to the overall 
uncertainty of the dosimeter if their contribution is different between the calibration phantom and the 
3D dosimeter phantom, e.g. as a result of different cooling rates of small phantoms as compared to 
large phantoms. When gel dosimeters are handled under conditions of good practice [37], the physico-
chemical mechanisms should not contribute to more than a total error of 2% in the dose measurement 
[38]. It is paramount that in some gel dosimeters (such as MAGAT) where a significant dose rate 
dependence is found [29], the figure of uncertainty may be exceeded. 
Also during irradiation there are different sources of stochastic variable contributions that 
determine the overall dosimetric precision such as variations in the dose delivery, variations in the 
temperature during irradiation [29, 30] and stochastic variations in the positioning of the calibration 
phantoms. Similar factors of chemical and irradiation uncertainty are also present with optical and X-
ray CT but their respective contribution may be different.  
MR images of the gel dosimeter will contain noise in the images as a result of thermal detector and 
phantom noise. This noise component will propagate into the derived quantitative MR images. The 
noise contribution is also determined by some scan parameters that can be optimized to achieve a 
maximum precision [34, 35]. In gel dosimetry with MRI readout, a calibration of the scanned 
parametric map (e.g. R2 map) is needed to obtain a dose map. The stochastic noise in the dose maps 
can be kept well below 0.8% standard deviation, resulting in a maximum deviation of 2.4% on an 
individual voxel basis with a confidence of 99% [24]. It is worth noting that the values mentioned here 
for thermal image noise are for imaging voxels with a volume of 3 mm3 and can be proportionally 
reduced by scaling to a grid size similar to the treatment plan. Any random errors that operate on the 
calibration samples will also affect the uncertainty of the dose map. In addition, the stochastic 
variations in beam output during radiation of the calibration vials can also be assumed to be 
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significantly less than 1% that is also supported by a reproducibility study where 20 (calibration) 
samples were irradiated with the same dose and under the same conditions. The resulting type A 
(random) uncertainty on the individual voxel level is therefore considered as predominantly 
originating from thermal noise during scanning. 
Systematic errors (type B uncertainty) during MRI scanning of gel dosimeters are attributed to: B0 
and B1-field non-uniformities; gradient non-uniformities; and temperature differences between 
calibration phantoms and volumetric dosimeter phantom [40-45]. Scanner related sources of 
uncertainty may be kept well below 3% by a proper scanning setup and/or by applying post-processing 
compensation methods such as for B0- and B1-field non-uniformity [2, 46]. A source of uncertainty 
that has a significant contribution to the overall uncertainty is related to temperature deviations and 
variations during scanning [39]. These effects can be minimized by use of an imaging sequence with 
centric k-space reordering [44] and/or an active temperature stabilization using thermal pads or a 
temperature stabilized water reservoir. An extensive set of guidelines on how to scan polymer gel 
dosimeters with MRI has been discussed in previous conference proceedings [37, 47].  
3.  Uncertainties in 3D dosimetry with optical readout 
Different optical scanner prototypes [48-60] have been developed to scan 3D dosimeters. As with MRI 
scanning of 3D dosimeters, the uncertainties are determined by the combination of the dosimeter 
characteristics and the optical scanner, which are often coupled and can’t be separated easily. For 
example, sensitivity to light scatter varies between scanner designs. As a result, the contribution of the 
uncertainty caused by light scattering in polymer gel dosimeters will depend on the scanner type.  
For polymer gel dosimeters, the same physico-chemical sources of uncertainties, as discussed in 
section 2, apply. It has also been found that variations in the fabrication process and chemical 
composition in both micelle gel dosimeters [61, 62] and plastic dosimeters such as PRESAGE [63-65] 
and Flexydos3D [66] result in inter-batch differences in the optical dose response. Although it is 
expected that intra-batch variations are minimal, until now, their effect on the uncertainty as a result of 
physico-chemical differences between calibration samples and volumetric dosimeter phantoms has not 
been investigated. Temperature dependence during irradiation in the order of 2% per degree Celsius 
has been detected in both PRESAGE [63, 64] and micelle gel dosimeters [62]. The Flexydos3D 
dosimeters are still under investigation. 
Detector noise will also contribute to pixel-by-pixel type A dose uncertainty. For CCD cameras, 
there is a square root relation between the noise and the signal intensity [67]. The propagation of noise 
from the detector noise to the signal-to-noise ratio (SNR) in the reconstructed optical density images 
can be easily simulated [67, 68]. It is found that the SNR in the reconstructed images also depends on 
the spatial frequency filter that is applied in the reconstruction algorithm. Computational simulations 
on synthetic phantoms can also be applied to detect the effect of the reconstruction algorithm on the 
modulation transfer function (MTF) and, hence, the spatial uncertainty introduced by the 
reconstruction [67, 68]. The spatial uncertainty can also be determined experimentally by using 
adequate resolution phantoms [54]. The SNR and the dynamic range of the detector are performance 
characteristics of the detector and are often associated with its cost. Just as with any other readout 
system, the SNR in the dose maps can be improved by averaging out several images at the cost of 
measurement time. The optimal dose range of the dosimeter is also determined by the SNR 
characteristics of the optical scanner, including both the detector noise performance and the 
reconstruction algorithm. 
Systematic errors (type B uncertainty) during optical scanning may affect both the spatial and dose 
accuracy and are related to imaging artefacts that can be both scanner related or phantom related. 
Phantom related artefacts are caused by refractive index differences between phantom and refractive 
index matching fluid [55], light scattering [56, 69], refractive index variations in the phantom as a 
result of convection during the exothermal solidification process [67] and granular impurities such as 
dust particles in the phantom [72]. Phantom related systematic errors that affect calibration may also 
originate from temperature differences during irradiation [62-64] and physico-chemical sources of 
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uncertainty such as temperature dependent auto-oxidation [70] of the leucodye and the effect of 
oxygen. Scanner related artefacts are scanner specific and can be caused by drift or fluctuations in the 
light source and/or detector [58, 71, 72], scratches on the optical components [71, 72], internal 
reflections in the optical components [71, 72], ambient stray light [71], desynchronization between 
galvanomirror and detector in laser scanners leading to misalignments in the sinogram [58, 72] and 
off-centric axis alignment with respect to the projections. Ray tracing [52] or Monte-Carlo simulation 
software [73] can be helpful in describing the performance of the scanner and in optimizing the design 
to minimize the instrumental uncertainties. Attempts to perform an independent calibration with 
calibration phantoms have been undertaken [71, 74, 75] but more studies are required to determine the 
achievable absolute dose accuracy with the various optically sensitive dosimeters. A comprehensive 
overview of optical scanning and tips-and-tricks can be found in previous conference proceedings [48, 
76].  
4.  Uncertainties in 3D dosimetry with X-ray CT readout 
All uncertainties and errors incurred during the PGD manufacture and irradiation steps of figure 2, and 
described above, are also present when imaging PGDs with x-ray CT. However, certain sensitivities, 
such as sensitivity to irradiation temperature, are less prevalent than when imaging with MRI. These 
observations speak to the low contrast resolution that is obtained when using x-ray CT for PGD 
imaging. 
Imaging PGDs with x-ray CT is associated with a distinct host of uncertainties and errors that must 
be considered within any given experiment. We here subdivide these uncertainties and errors in to two 
categories: those induced through the imaging procedure; and those induced through post image 
acquisition processing. Within the imaging procedure, uncertainties within a resultant image are 
compounded by set-up errors and signal to noise ratio (SNR) considerations through imaging 
parameter optimization. An attractive feature of x-ray CT PGD is the fact that the CT process is 
already incorporated into the radiotherapy work-flow. Hence, physical set-up errors can be minimized 
through the use of standardized immobilization devices that are constant throughout the experiment 
(from treatment plan CT acquisition through to dose information extraction imaging). With rigorous 
attention to phantom set-up reproducibility, a ~1mm accuracy in set up can be achieved with an 
anthropomorphic head phantom and CT mask immobilization. In terms of imaging parameter 
optimization, work has been reported in the literature outlining the affects of parameter manipulation 
on resultant image SNR [36]. Image SNR can be optimized through judicious choice of CT parameter 
acquisition. While SNR can be improved through, essentially increasing the number of photons hitting 
any given detector, such a scheme comes at the expense of tube load and, therefore, image acquisition 
time, which is restricted by any required tube cooling. 
Post CT imaging, data processing is required to convert raw CT images to high SNR dose maps. 
Figure 3 illustrates factors affecting systematic and random errors and uncertainties incurred through 
each processing step. Each step throughout the procedure outlined in figure 3 carries with it an 
inherent uncertainty which, ultimately, propagates through to the dose calibration function and hence 
also through to the calibrated dose maps. Recent work has incorporated errors throughout each step in 
order to obtain an estimation of the accuracy and precision in calibrated CT images.  Results show that 
accuracy and precision throughout the calibration procedure are highly dose dependent and hence a 
single quantity for accuracy or precision can not be realistically quoted. Minimum errors in accuracy 
and precision occur in the “mid-dose” regions (~7 – 20 Gy) of the calibration and are quoted in the 5% 
range. It must also be noted that a non-linear calibration curve was essential in performing the 
“absolute” calibration in this case. Several non-linear functions were tested and a hyperbolic tangent 
function was found to provide the highest level of accuracy and precision in the resultant dose maps. 
This function was found empirically and does not necessarily offer insight in to reaction dynamics 
within PGDs, although this point has not been investigated in depth. In summary, a linear calibration 
would result in highly increased errors and is therefore not recommended when performing x-ray CT 
PGD. 
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Figure 3. PGD CT image processing procedure with associated optimization parameters and errors. Red right-
pointing arrows indicate an error propagation step. Taken from Jirasek et al 2014 with permission from Jirasek et 
al 2012. 
5.  Conclusions 
Polymer gel dosimetry remains one of the most promising tools for measuring inherently complex 3D 
radiotherapy dose distributions. In fact, polymer gel dosimetry is currently feasible with MRI-based 
dose readout. However, the uncertainties within a given polymer gel system, irrespective of the 
imaging modality used to extract dose information, are non-trivial in nature and great care is required 
in understanding the magnitudes of errors and uncertainties within a full gel dosimetry protocol. With 
every dosimeter and imaging modality it is crucial to follow a careful optimized protocol and 
compensate for imaging artefacts to minimize the uncertainties. This review poses points for 
consideration when undertaking a benchmarking of accuracy and precision of polymer gel dosimetry 
imaged with MRI, optical or x-ray CT. 
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